GL1X · GenesisL1 explorer

Research workbench

Mazf from S. aureus crystal form II, C2221, 2.3 a

Analyse Mazf from S. aureus crystal form II, C2221, 2.3 a in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MZT
Type
protein
Length
227 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mazf mRNA interferase
EC
3.1.-.-
UniProt
Q7A4G9
Pockets
1 · best druggability 0.26

Structure

x-ray diffraction · 2 distinct chains · 20% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMazf mRNA interferase (EC 3.1.-.-)protein11420% helix, 38% strandQ7A4G9
BMazf mRNA interferase (EC 3.1.-.-)protein11320% helix, 38% strandQ7A4G9

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1500.260.7415empty

Interfaces

1 interface between chains.

  • A–B · 1294 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 4MZT · MazF from S. aureus crystal form II, C2221, 2.3 A · the same entry in another collection · chain A against A, TM-score 1.00
  • Q7A4G9 · AlphaFold monomer V2.0 prediction for endoribonuclease mazf (Q7A4G9) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.